Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma

NCT02433834 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

248

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Glycopyrronium MDI
DRUG: Serevent Diskus 50 μg
DRUG: Placebo

Sponsor

Pearl Therapeutics, Inc.